STAAR Surgical Stock Analysis
| STAA Stock | USD 28.18 0.35 1.26% |
STAA is currently below model estimate with Market Value of 28.18 and Intrinsic Value of 29.72. The framework below evaluates STAA by comparing modeled intrinsic value to current market pricing. STAA is operating at a loss, which shifts analytical weight from valuation multiples toward margin trajectory and cash flow sustainability.
STAA holds a debt-to-equity ratio of 0.1 relative to health care peers. STAAR Surgical's leverage relative to sector peers provides context — the same debt ratio carries different implications across industries. Earnings before interest and taxes (EBIT) relative to interest expense measures the margin of safety on debt service. Asset vs Debt
Equity vs Debt
STAAR Surgical |
Investor Insights and Alerts
A concise alert layer for STAAR Surgical can improve discipline because it turns scattered risk signals into a more reviewable checklist. The strongest alert framework is one that makes risk easier to acknowledge before the market fully reprices it.
| STAAR Surgical appears to be risky and price may revert if volatility continues | |
| STAA reported previous year's revenue of $239.44 million. Net Loss for the year was -$80.45 million with profit before overhead, payroll, taxes, and interest of $182.42 million. | |
| Latest reporting shows about $202.49 million in cash alongside -$34.23 million of negative cash flow from operations. Cash per share is 4.22. | |
| Latest headline from fool.com: PLSE Q 1 2026 Earnings Transcript |
Market Capitalization
Market capitalization is $1.33 billion, placing the company in the mid-cap tier across health care companies. Related scale indicators include a workforce of about 921 people, operating in the Health Care industry, and enterprise value near $1.18 billion.Profitability
Understanding STAAR Surgical's profitability goes beyond headline earnings. Margin durability, leverage, and capital needs all matter. The best read combines margin history with balance-sheet strength and pricing power under softer demand. STAA has Profit Margin (PM) of -34.0%. Similarly, it shows Operating Margin (OM) of -19.0%.Technical Drivers
As of the 13th of May 2026, STAAR Surgical trades at 28.18 per share. Key technical indicators include downside deviation of 3.63, and Risk Adjusted Performance of 0.1948. The technical model evaluates historical price movement, trading volume, and volatility patterns to quantify trend strength. Current values are evaluated relative to sector peers and historical ranges.Price Movement Analysis - Bollinger Bands
This analysis covers sixty data points across the selected time horizon. The Extended Parabolic SAR indicator is used to determine the direction of STAAR Surgical's momentum and the point in time when it has higher than normal probability of directional change. It has more input parameters than standard Parabolic SAR indicator.
Insider Trading Activities
The analytical value in STAAR Surgical's insider filings lies in transaction clustering, trade size, and timing relative to price movements rather than any single filing. The pattern is informative when compared with earnings releases and guidance changes rather than treated alone.
Outstanding Bonds
Outstanding bonds linked to STAAR Surgical can tell investors a great deal about how the company finances itself beyond common equity markets. Longer-dated obligations can improve financing stability, but they also leave investors more exposed if the underlying business weakens before the debt matures.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| US85236FAA12 Corp BondUS85236FAA12 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Predictive Daily Indicators
Daily signals in STAAR Surgical help active traders track momentum, reversals, and volume pressure during the session. The best setups combine these signals with strict risk limits, since short-term data can reverse fast when liquidity thins.
Forecast Models
Forecasting applied to STAAR Surgical learns from price structure, volatility patterns, and trend strength rather than commentary alone. The practical edge is not the forecast number itself, but knowing when the data is becoming less predictable.Debt to Cash Allocation
The debt-to-cash mix for STAAR Surgical helps explain how management balances flexibility and funding cost through a business cycle.
Total debt stands at approximately $38.35 million with Debt to Equity (D/E) ratio of 0.1. STAAR Surgical has a current ratio of 6.24, suggesting that it is liquid enough and is able to pay its financial obligations when due. STAAR Surgical's use of debt should be considered alongside its cash position and equity base.Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the STAAR Surgical's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of STAAR Surgical, which in turn will lower the firm's financial flexibility.Corporate Bonds Issued
Bond maturity for STAAR Surgical is a core risk dimension. Longer duration can offer higher yield, but price sensitivity and credit uncertainty also increase.
Stock Analysis Methodology
As a small-cap equity, STAAR Surgical diagnostic profile covers valuation ratios, fundamentals, and technical signals. STAAR Surgical trades at P/E of 460.83, P/B of 3.86. STAAR Surgical shows ROE (TTM) of -21.7% and net margin (TTM) of -33.6%.
Reported values for STAAR Surgical are derived from periodic company reporting and market reference feeds and standardized for analysis.
Editorial review and methodology oversight provided by: Ellen Johnson, Member of Macroaxis Editorial Board
Be Your Own Money Manager
Building wealth with STAAR Surgical still requires portfolio discipline because one position merits evaluation by how it improves total return efficiency, not just by its standalone upside. The practical goal is to improve diversification, remove redundancy, and keep return expectations realistic.